Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Giovanni Grillo"'
Autor:
Giovanni Marconi, Alfonso Piciocchi, Sabina Chiaretti, Cristina Papayannidis, Monia Lunghi, Prassede Salutari, Patrizia Zappasodi, Alessandro Rambaldi, Attilio Olivieri, Maurizio Cavallari, Stefano Soddu, Nicola S Fracchiolla, Federica Gigli, Chiara Cattaneo, Daniele Giovanni Mattei, Anna Candoni, Giovanni Grillo, Maria Chiara Abbenante, Ernesta Audisio, Massimiliano Bonifacio, Albana Lico, Roberto Massimo Lemoli, Paolo De Fabritiis, Felicetto Ferrara, Martina Rachele Marino, Monica Messina, Anna Ferrari, Valentina Robustelli, Jacopo Nanni, Irene Della Starza, Giorgia Simonetti, Maria Stefania De Propris, Maria Teresa Bochicchio, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Publikováno v:
Blood. 140:6119-6121
Autor:
Piero Galieni, Mario Luppi, Giovanni Grillo, Paola Carluccio, Ursula La Rocca, Paolo Nicoli, Luisa Giaccone, Chiara Nozzoli, Simona Bassi, Patrizio Mazza, Attilio Olivieri, Renato Fanin, Filippo Antonio Canale, Eugenia Piras, Benedetto Bruno, Sonia Mammoliti, Anna Proia, Stella Santarone, Massimo Martino, Adriana Vacca, Fabio Ciceri, Patrizia Chiusolo, Giulia Debbia, Ilaria Cutini, Anna Colombo, Marco Casini, Ilaria Scortechini, Carmine Selleri, Carlo Borghero, Cristina Skert, Francesca Elice, Maria Teresa Lupo Stanghellini, Mario Arpinati, Domenico Russo, Vicky Rubini, Anna Paola Iori, Emanuela Merla, Elena Oldani, Giorgia Saporiti, Anna Mele, Francesca Patriarca, Fulvia Fanelli, Nicola Polverelli, Francesca Bonifazi, Sadia Falcioni, Vincenzo Pavone, Francesca Carobolante, Francesco Onida, Luca Castagna, Elisabetta Metafuni, Danilo Giuseppe Faraci, Stefania Bramanti, Elisabetta Terruzzi, Paolo Bernasconi, Annamaria Mazzone, Annalisa Natale, Irene Cavattoni, Marco De Gobbi, Michele Malagola, Nicoletta Sacchi, Angelo Michele Carella
Publikováno v:
Blood. 138:1786-1786
The upper age-limit for patients with hematological malignancies eligible for allo-SCT progressed to 70-75 years. As a consequence, an increase of older patients submitted to allo-SCT has been observed worldwide and in Italy as well. This registry-ba
Autor:
Jeff Szer, Gérard Socié, Karen Sinclair, Shalini Chaturvedi, Mohamad Mohty, Jason Butler, Anirudh Prahallad, Eva Wagner, Edouard Forcade, C. Wilke, Tsila Zuckerman, David Ritchie, Nikolas von Bubnoff, Giovanni Grillo, Dietger Niederwieser, Sinem Civriz Bozdag, Domenico Russo, Reuven Or, Robert Zeiser, Jaime Sanz Caballer
Publikováno v:
Blood. 136:26-27
BACKGROUND aGVHD, a common complication of allogeneic stem cell transplant (alloSCT), is driven by proinflammatory cytokines and chemokines that activate the immune system, resulting in end-organ damage. Steroids are first-line treatment but up to 50
Autor:
Massimo Martino, Zafer Gulbas, Fabrizio Pane, Emanuele Angelucci, Simona Sica, Ivan S. Moiseev, Yener Koc, Mohamad Mohty, Mercedes Colorado Araujo, Mutlu Arat, Hans Martin, Arnon Nagler, José Luis Díez-Martín, Annalisa Ruggeri, Benedetto Bruno, Giovanni Grillo, Didier Blaise, Myriam Labopin, Giorgia Battipaglia, Jacques-Emmanuel Galimard, Lucía López Corral, Luca Castagna, Montserrat Rovira, Antonin Vitek, Fabio Ciceri
Publikováno v:
Blood. 136:26-27
Introduction. In the absence of an HLA-identical sibling or a matched unrelated donor, whether to prefer a Haploidentical (Haplo) or a one antigen mismatched unrelated donor (MMUD) for allogeneic hematopoietic cell transplantation (HCT) remains an un
Autor:
Rosa Greco, Giovanni Grillo, Elisa Diral, Marta Riva, Roberto Cairoli, Silvio Veronese, Michele Nichelatti, Valentina Mancini, Elisa Zucchetti, Lorenzo Rizzo, Giambattista Bertani
Publikováno v:
Blood. 136:20-21
Background: The treatment for relapsed or refractory acute myeloid leukemia (R/R AML) has minimal chances and a low impact on improving survival. One of the most important goal is to treat unfit patients who are often intolerant to intensive chemothe
Autor:
Alessandro Beghini, Gianluigi Reda, Roberto Cairoli, Francesca Lazzaroni, Adriana Cassaro, Giovanni Grillo
Publikováno v:
Blood. 134:3956-3956
Background Wnt/Fzd signaling is known to play a pervasive influence in hematopoietic stem cell maintenance, T-cell development in the thymus and function as well as an important role in T-cell acute lymphoblastic leukemia (T-ALL) establishment. We ha
Autor:
Sabri Boughorbel, Rebecca Mathew, Catherine H. Cole, Mohammed Elanbari, Merav Bar, Mohammed Toufiq, Giovanni Grillo, Sabine Forer, Sara Tomei, Damien Chaussabel, Darawan Rinchai, Alice Woo, Patrizia Comoli, Chiara Cugno, Irene Cavattoni, Valentina Mattei, Sara Deola, Marco Zecca
Publikováno v:
Blood. 134:4550-4550
Introduction Allogeneic Hematopoietic Cell Transplantation (allo HCT) is currently the only curative therapy for high-risk hematologic malignancies due to the immune response of the donor cells against the malignant cells (graft versus tumor effect;
Autor:
Elisabetta Volpato, Elisa Zucchetti, Roberto Cairoli, Mariateresa Pugliano, Tiziana Lamacchia, Laura Pezzetti, Giovanni Grillo, Liliana Intropido, Giambattista Bertani
Publikováno v:
Blood. 134:5633-5633
BACKGROUND Plerixafor (PLX) blocks the binding of stromal cell-derived factor to CXCR4, resulting in hematopoietic stem cell (HSC) release from the bone marrow. It has been successfully used as a mobilizing agent in poor mobilizers (PM). The best str
Autor:
Alessandro Monti, Enrica Morra, Marianna Caramella, Antonino Greco, Vittorio Ruggero Zilioli, Chiara Rusconi, Elisa Zucchetti, Michele Nichelatti, Cristina Gabutti, Giovanni Grillo, Maddalena Mazzucchelli, Erika Meli
Publikováno v:
Blood. 120:4851-4851
Abstract 4851 Background: Primary Mediastinal B-Cell Lymphoma (PMBL) is an uncommon disease, characterized by aggressive and invasive course but with a good prognosis after anthracycline-based chemotherapy. In the PET era the role of consolidation ra
Autor:
Silvio Veronese, Alessandra Tedeschi, Giovanni Grillo, Marco Montillo, Enrica Morra, Eleonora Vismara, Francesca Ricci, Sara Miqueleiz, Antonino Greco
Publikováno v:
Blood. 112:2182-2182
The role of an intensified program of autologous stem cell transplantation (ASCT) following a consolidation phase with alemtuzumab (A) in pts with chronic lymphocytic leukemia (B-CLL) who received a fludarabine-based regimen (Fbr) as debulking is sti